Incretin-based therapy: renal effects
Glucagon like peptide-1 (GLP-1) analogues and dipeptidyl peptidase-4 (DPP-4) inhibitors are new classes of hypoglycemic agents with numerous pleiotropic effects. The review summarises data about the influence of GLP-1 analogues and DPP-4 inhibitors on structural and functional changes in diabetic ki...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN RU |
| Publié: |
Endocrinology Research Centre
2016
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/5c2fe686f9b64d1a9647f4b4cad14b69 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|